Metraipolis › archive › dc_fe78e7055173
BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis — Europe PMC PMID:41464754
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41464754
- DOI
- 10.3390/jcm14248854
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T16:01:17.938Z
- SHA-256 of the archived text
a54c48527d6c96c8fbbf4962aa7368c4826ccacd32c3a0c42f4829ddf22ddd9f- Stable URL of this page
https://metraipolis.com/documento/dc_fe78e7055173
How to cite
BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis — Europe PMC PMID:41464754 — Europe PMC (en), https://europepmc.org/article/MED/41464754 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe78e7055173 (Metraipolis archive dc_fe78e7055173, sha256 a54c48527d6c96c8fbbf4962aa7368c4826ccacd32c3a0c42f4829ddf22ddd9f)
BibTeX
@misc{dcfe78e7055173,
title = {BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis — Europe PMC PMID:41464754},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41464754},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe78e7055173; sha256 a54c48527d6c96c8fbbf4962aa7368c4826ccacd32c3a0c42f4829ddf22ddd9f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41464754. Agents can read the archived copy with the MCP tool read_document.